PMC:7346000 / 23596-24007 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"662","span":{"begin":309,"end":317},"obj":"Species"},{"id":"663","span":{"begin":330,"end":340},"obj":"Species"},{"id":"680","span":{"begin":20,"end":33},"obj":"Chemical"},{"id":"681","span":{"begin":44,"end":56},"obj":"Chemical"},{"id":"682","span":{"begin":76,"end":90},"obj":"Chemical"},{"id":"697","span":{"begin":164,"end":183},"obj":"Disease"},{"id":"698","span":{"begin":318,"end":326},"obj":"Disease"},{"id":"699","span":{"begin":357,"end":370},"obj":"Disease"}],"attributes":[{"id":"A662","pred":"tao:has_database_id","subj":"662","obj":"Tax:9606"},{"id":"A663","pred":"tao:has_database_id","subj":"663","obj":"Tax:2697049"},{"id":"A680","pred":"tao:has_database_id","subj":"680","obj":"MESH:C508735"},{"id":"A681","pred":"tao:has_database_id","subj":"681","obj":"MESH:D065819"},{"id":"A682","pred":"tao:has_database_id","subj":"682","obj":"MESH:D000666"},{"id":"A697","pred":"tao:has_database_id","subj":"697","obj":"MESH:D051437"},{"id":"A698","pred":"tao:has_database_id","subj":"698","obj":"MESH:D007239"},{"id":"A699","pred":"tao:has_database_id","subj":"699","obj":"MESH:D007674"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"less a problem with isavuconazole than with voriconazole [85,86]. Liposomal amphotericin B is a broadly effective alternative treatment option, however, in the ICU renal insufficiency often complicates initiation or requires discontinuation of this antifungal agent. This concern is particularly relevant for patients infected by SARS-CoV-2 which has shown renal tropism and been described as a frequent cause o"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T198","span":{"begin":164,"end":183},"obj":"Disease"},{"id":"T199","span":{"begin":330,"end":338},"obj":"Disease"}],"attributes":[{"id":"A198","pred":"mondo_id","subj":"T198","obj":"http://purl.obolibrary.org/obo/MONDO_0001106"},{"id":"A199","pred":"mondo_id","subj":"T199","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"less a problem with isavuconazole than with voriconazole [85,86]. Liposomal amphotericin B is a broadly effective alternative treatment option, however, in the ICU renal insufficiency often complicates initiation or requires discontinuation of this antifungal agent. This concern is particularly relevant for patients infected by SARS-CoV-2 which has shown renal tropism and been described as a frequent cause o"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T190","span":{"begin":5,"end":6},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T191","span":{"begin":89,"end":90},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T192","span":{"begin":94,"end":95},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T193","span":{"begin":347,"end":350},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T194","span":{"begin":393,"end":394},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"less a problem with isavuconazole than with voriconazole [85,86]. Liposomal amphotericin B is a broadly effective alternative treatment option, however, in the ICU renal insufficiency often complicates initiation or requires discontinuation of this antifungal agent. This concern is particularly relevant for patients infected by SARS-CoV-2 which has shown renal tropism and been described as a frequent cause o"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T157","span":{"begin":20,"end":33},"obj":"Chemical"},{"id":"T158","span":{"begin":44,"end":56},"obj":"Chemical"},{"id":"T159","span":{"begin":76,"end":90},"obj":"Chemical"},{"id":"T160","span":{"begin":249,"end":265},"obj":"Chemical"}],"attributes":[{"id":"A157","pred":"chebi_id","subj":"T157","obj":"http://purl.obolibrary.org/obo/CHEBI_85979"},{"id":"A158","pred":"chebi_id","subj":"T158","obj":"http://purl.obolibrary.org/obo/CHEBI_10023"},{"id":"A159","pred":"chebi_id","subj":"T159","obj":"http://purl.obolibrary.org/obo/CHEBI_2682"},{"id":"A160","pred":"chebi_id","subj":"T160","obj":"http://purl.obolibrary.org/obo/CHEBI_35718"}],"text":"less a problem with isavuconazole than with voriconazole [85,86]. Liposomal amphotericin B is a broadly effective alternative treatment option, however, in the ICU renal insufficiency often complicates initiation or requires discontinuation of this antifungal agent. This concern is particularly relevant for patients infected by SARS-CoV-2 which has shown renal tropism and been described as a frequent cause o"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T33","span":{"begin":363,"end":370},"obj":"http://purl.obolibrary.org/obo/GO_0009606"}],"text":"less a problem with isavuconazole than with voriconazole [85,86]. Liposomal amphotericin B is a broadly effective alternative treatment option, however, in the ICU renal insufficiency often complicates initiation or requires discontinuation of this antifungal agent. This concern is particularly relevant for patients infected by SARS-CoV-2 which has shown renal tropism and been described as a frequent cause o"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T50","span":{"begin":164,"end":183},"obj":"Phenotype"}],"attributes":[{"id":"A50","pred":"hp_id","subj":"T50","obj":"http://purl.obolibrary.org/obo/HP_0000083"}],"text":"less a problem with isavuconazole than with voriconazole [85,86]. Liposomal amphotericin B is a broadly effective alternative treatment option, however, in the ICU renal insufficiency often complicates initiation or requires discontinuation of this antifungal agent. This concern is particularly relevant for patients infected by SARS-CoV-2 which has shown renal tropism and been described as a frequent cause o"}

{"project":"LitCovid-sentences","denotations":[{"id":"T126","span":{"begin":66,"end":266},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"less a problem with isavuconazole than with voriconazole [85,86]. Liposomal amphotericin B is a broadly effective alternative treatment option, however, in the ICU renal insufficiency often complicates initiation or requires discontinuation of this antifungal agent. This concern is particularly relevant for patients infected by SARS-CoV-2 which has shown renal tropism and been described as a frequent cause o"}

{"project":"2_test","denotations":[{"id":"32599813-29112326-60095153","span":{"begin":61,"end":63},"obj":"29112326"}],"text":"less a problem with isavuconazole than with voriconazole [85,86]. Liposomal amphotericin B is a broadly effective alternative treatment option, however, in the ICU renal insufficiency often complicates initiation or requires discontinuation of this antifungal agent. This concern is particularly relevant for patients infected by SARS-CoV-2 which has shown renal tropism and been described as a frequent cause o"}